Apr 02, 2019
Sangamo Provides Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data
Apr 01, 2019
Sangamo Therapeutics To Host April 2, 2019 Conference Call To Provide Clinical Update
Mar 29, 2019
Sangamo Therapeutics Presents New Preclinical Data Demonstrating Significant Reduction In Tau Expression With Gene Regulation Technology
Mar 25, 2019
Cardea Bio Announces New Partnership with Nanosens Innovations
Mar 25, 2019
CRISPR-Chip Enables Digital Detection of DNA without Amplification
Mar 08, 2019
Cellectis Enters Lease Agreement to Build Manufacturing Facility, Advancing Towards Commercialization of its UCART Portfolio
Mar 06, 2019
Sangamo Therapeutics Announces Participation At Upcoming Investor Conferences
Mar 05, 2019
Genome Editing: Technologies and Global Markets
Feb 27, 2019
Synthego Launches $1 Million in Grants to Foster Innovation and Accelerate Discovery in Genome Engineering Research
Feb 19, 2019
MilliporeSigma Receives First U.S. Patent for Improved CRISPR Genome-Editing Method
Feb 07, 2019
Sangamo Announces Interim Results Of Phase 1/2 CHAMPIONS Study Showing Preliminary Evidence Of In Vivo Genome Editing In Patients With MPS II Treated With SB-913
Feb 07, 2019
Sangamo Announces Interim Results Of Phase 1/2 EMPOWERS Study Evaluating SB-318 Zinc Finger Nuclease (ZFN) In Vivo Genome Editing Demonstrating Increased Leukocyte IDUA Activity In Patients With MPS I
Feb 01, 2019
Sangamo Therapeutics To Host Conference Call To Review Interim Results From Phase 1/2 CHAMPIONS And EMPOWERS Studies For MPS II And MPS I
Jan 29, 2019
Promega Corporation Enters License Agreement with Broad Institute to Access CRISPR-Cas9 Gene Editing Technology
Jan 24, 2019
Merck KGaA, Darmstadt, Germany, Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
Jan 04, 2019
Sangamo Announces Upcoming Clinical Data Presentations At WORLDSymposium 2019
Dec 13, 2018
ERS Genomics and Lonza Enter Into CRISPR/Cas9 Technology Licensing Deal
Dec 11, 2018
GenEdit Closes $8.5 million Series Seed Financing
Dec 11, 2018
Cellectis Appoints William Monteith as Senior Vice President U.S. Manufacturing
Dec 10, 2018
MilliporeSigma and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models